The impact of COVID-19 pandemic can be felt across the Healthcare Industry The growing inability in the production and manufacturing processes, in the light of the self-quarantined workforce has caused a major disruption in the supply chain across the sector. Restrictions encouraged by this pandemic are obstructing the production of essentials such as life-saving drugs.
The nature of operation in Pharmaceuticals plants that cannot be easily stopped and started, makes the operational restrictions in these plants a serious concern for the industry leaders. Restricted and delayed shipments from China have created a price hike in the raw materials, affecting the core of the Healthcare Industry
The slacking demand from different impacted industries such as automotive is negatively influencing the growth of the Healthcare Industry. In light of the current crisis, the market leaders are focused to become self-reliant which is expected to benefit the economic growth of different economies in the longer term. Companies are triggering events to restructure and recover from the losses incurred during the COVID-19 pandemic.
To remain ‘ahead’ of your competitors, request for a sample [email protected] https://www.persistencemarketresearch.com/samples/27808
Enteral nutrition administration is the administration of food and drug via human gastrointestinal tract. This is different from the parenteral nutrition or drug administration which occurs from routes such as intravenous. Enteral nutrition associates esophagus, small intestine large intestine. The Enteral nutrition indicates method of feeding that involves gastrointestinal tract to deliver calorie requirements to the patients. It includes the usage of liquid supplements or its delivery to by tube feedings. The food enters directly to the stomach or small intestine. The food with enteral nutrition is preferable among enteral and parenteral nutrition as it closely imitates regular eating and helps with the immune system function. Also the enteral nutrition helps premature infants to gain appropriate medications and nutrition.
Mostly enteral nutrition is prescribed to patients who are unable to consume nutrients or food and have difficulty in swallowing but has operative gastrointestinal tract. The enteral nutrition is suggested to patients suffering from malnutrition, cancer or gastrointestinal disorders. Increasing prevalence of chronic diseases and illness such as neurological disorders and diseases such as cancer are the key factors which are driving the growth of enteral nutrition market. Also government is putting efforts to curb malnutrition which will drive the growth of enteral nutrition market. In case of administration through feeding tube single nutrient is such as protein, carbohydrates or fats are administered to treat specific deficiency or combined with other powders to satisfy the nutritional requirements. Also the tube feeding can be given several times or by continuous infusion.
To receive extensive list of important regions, ask for TOC here @ https://www.persistencemarketresearch.com/toc/27808
Tentatively, Enteral Nutrition Market has been segmented on the basis of route of administration, product type, application, and end user.
On the basis of Route of Administration, Enteral Nutrition Market can be segmented as:
- Oral administration by mouth
- Administration through feeding tube
On the basis of Product Type, Enteral Nutrition Market can be segmented as:
- Powder form
- Liquid form
On the basis of Applications, Enteral Nutrition Market can be segmented as:
- Heart diseases
On the basis of end users, Enteral Nutrition Market can be segmented as:
- Long Term Care Facilities
- Home care centers
Demand for Enteral nutrition will increase as it is more preferred due to ease of access and improvements in safety. Also the enteral nutrition treatment can be used at home which is an advantage for the patients. Support from the government to remove eliminate malnutrition from the emerging countries such as India, Brazil will improve the market for enteral nutrition. According to Boston Scientific approximately 340,000 people of all age groups in the U.S. depend on enteral feeding for nutrition which would further increase and expand the enteral nutrition market.
Geographically, global Enteral Nutrition Market is divided into regions viz. Latin America, North America, Western Europe, Middle East & Africa, Asia Pacific, and Eastern Europe. North America’s Enteral Nutrition Market is spreading because of its widespread acceptance, which is further owing to enhancement and better ingredients and techniques which would make positive impact on the patient’s health conditions. Also low cost and less complications with the enteral nutrition increase the growth of the market. Increased health care expenditure and government support are the additional factors which will remain dominant over the forecast period for the enteral nutrition market. However harsh government regulations and ejection of tubes could lead to accidents and further hamper the growth of the market. With the development of advanced products in the future enteral nutrition market is expected to provide gainful opportunities for the manufacturers in future.
For in-depth competitive analysis, Check Pre-Book here @ https://www.persistencemarketresearch.com/checkout/27808
Some of the major market players in the Global Enteral Nutrition Market identified across the value chain include:
- Nestle S.A.
- B. Braun Holding GmbH & Co. KG
- Baxter International Inc.
- Abbott Laboratories
- Perrigo Company Plc.
- Reckitt Benckiser Group Plc
- Groupe Danone
- Meiji Seika Pharma Co. Ltd.
- Fresenius Kabi AG
- Aveanna Healthcare
- Danone Nutricia
- Shield HealthCare, Inc
The Enteral Nutrition Market report provides in-depth analysis of parent market trends, governing factors and macro-economic indicator and along with market attractiveness as per segments. Also the report is a compilation of qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report also outlines the qualitative impact of different market factors on market segments and geographies.
Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape
Sleep Disorder Therapeutics Market – According to a press release in March 2014 by World Association of Sleep Medicine, 45% of the global population suffers from some form of sleep disorder. It also mentions that approximately 25% male and 10% females in the U.S. suffer from sleep apnea. This high prevalence suggests an opportunity for a large therapeutics market.For More Information.
Throat Lozenges Market – The growth of the market for throat lozenges will be driven by aging population since elderly people often suffer from throat infection that increase the uptake of throat lozenges. It has been projected by the World Health Organization (WHO) that by 2050 nearly 2 billion populations will belong to geriatric population and it also estimated that global elderly population was 524 million in 2010.For More Information.